<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2021</study_start_year><condition>metastatic colorectal cancer</condition><disease>Metastatic Colorectal Cancer</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/81286</full_dataset_link><location>China</location><study_start_month>12</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>A Retrospective-Prospective observational study in China to describe the management in clinical practice of adult patients with metastatic colorectal cancer (CRC) with a BRAF V600E  mutation who have received prior systemic therapy</name><description>Interventions: Retrospective group:None;Prospective group:None
Primary outcome(s): Describe the treatment path of the target population
Study Design: Sequential</description><dates><creation>2021-12-15</creation></dates><accession>81286</accession><cross_references><Chinese Clinical Trial Register>ChiCTR2200065134</Chinese Clinical Trial Register></cross_references></HashMap>